The NDDoH viral hepatitis program receives state and federal funding from the U.S. Centers for Disease Control and Prevention (CDC) to enhance and support viral hepatitis programs. The key activities of the viral hepatitis program include:
- Monitoring the incidence and estimated prevalence of viral hepatitis in the state. Diseases that are monitored include: hepatitis A, hepatitis B and hepatitis C.
- Educating health care professionals that serve individuals at risk for viral hepatitis and target populations who are at risk for viral hepatitis.
- Collaborating with the HIV program to integrate viral hepatitis testing into the counseling, testing and referral (CTR) program for those at risk for viral hepatitis infections. These individuals are also offered hepatitis A and B vaccinations.
- Develop referral services for medical care and case management for chronically infected persons.
These activities aim to reduce the number of cases of viral hepatitis in North Dakota. They also increase opportunities for individuals to seek risk reduction counseling, as well as vaccination to prevent and testing to identify viral hepatitis infections.
Everyone has a viral hepatitis status, do you know your status? The only way to know if you are infected with hepatitis B or hepatitis C is to get tested. Knowing your status gives you powerful information to keep you and your partner healthy.
Syringe Service Programs
Syringe services programs (SSPs) are community-based prevention programs that can provide a range of services, including linkage to substance use disorder treatment; access to and disposal of sterile syringes and injection equipment; and vaccination, testing, and linkage to care and treatment for infectious diseases.
The NDDoH along with ND communities and partners are working towards Hepatitis Elimination. The NDDoH is working to establish a community advisory board that will enhance partnerships and collaborations across many entities and healthcare providers in North Dakota to address the viral hepatitis epidemic in North Dakota.
The Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025 provides a framework to eliminate viral hepatitis as a public health threat in the United States by 2030. The Viral Hepatitis Plan focuses on hepatitis A, hepatitis B, and hepatitis C—the three most common hepatitis viruses that have the most impact on the health of the nation.
Health Care Provider
Health care providers are important partners in effective HIV prevention and treatment that occurs across a continuum of care. There are many tools and information available across the HIV continuum, including up-to-date tools and guidelines for your practice, and educational materials for your patients.
Education and Events
Available education and training events are intended for primary care physicians, infectious disease specialists, nurses, and public health and preventive medicine specialists. These educational opportunities focus on best practices related to HIV, STI, TB and viral hepatitis prevention, testing and treatment.
Frequently Asked Questions
Hepatitis means inflammation of the liver. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. Here are some frequently asked questions about the hepatitis viruses: